J. Gubbay

Surveillance and outbreak report Interim estimates of 2015 / 16 vaccine effectiveness against influenza A ( H 1 N 1 ) pdm 09 , Canada , February 2016

N. Bastien, C. Chambers, M. Krajden, 2016 .

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

P. Austin, K. Wilson, J. Kwong, 2022, Nature Communications.

Real-time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with Variants of Concern

V. Allen, T. Mazzulli, N. Fittipaldi, 2021, medRxiv.

The role of torovirus in nosocomial viral gastroenteritis at a large tertiary pediatric centre.

A. Matlow, M. Hawkes, J. Gubbay, 2012, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results

V. Allen, T. Mazzulli, N. Fittipaldi, 2021, medRxiv.

Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.

D. Skowronski, K. Fonseca, P. V. Van Caeseele, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Effectiveness of COVID-19 vaccines against Omicron or Delta infection

M. Sundaram, K. Brown, S. Buchan, 2022, medRxiv.

Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged >=50 years in Ontario, Canada

K. Brown, S. Buchan, J. Kwong, 2023, medRxiv.

Strengths and limitations of assessing influenza vaccine effectiveness using routinely collected, passive surveillance data in Ontario, Canada, 2007 to 2012: balancing efficiency versus quality.

D. Skowronski, L. Rosella, N. Crowcroft, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults

K. Brown, S. Buchan, J. Kwong, 2023, medRxiv.

Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13

A. N. Robertson, D. Fleming, C. Robertson, 2013 .